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The Australasian Diabetes Data Network (ADDN) is a
collaboration that aims to collect and centrally collate a
suite of patient data across Australia and New Zealand
that will be available to all diabetes researchers. ADDN
will collect information prospectively, facilitating data
sharing and building capacity in clinical service delivery
and investigation. The central database will provide a
research resource, facilitate study recruitment and be an
ongoing source of data to enable benchmarking against
national outcomes. By April 2015 ADDN will be popu-
lated with over 4,000 participants presenting an oppor-
tunity to analyse national data for the first time. To date
ADDN holds the data of 1136 children and adolescents.
Of the T1D participants (n=1064), males and females
were equally represented, with 3% (35) aged <5, 19%
(200) aged 5-10, 37%( 396) aged 10-15, 38%( 399) aged
15-20 and 3%( 34) >20 years of age. A total of 10% were
treated with twice daily injections, 42% with Multiple
Daily Injections and 47% with continuous subcutaneous
insulin infusion (CSII). The TID group had a median
HbA1c of 8% (64 nmol/mol) with 31% (330) <7.5%
(58.5 nmol/mol), 42% (447) 7.5-9.0 (58.5-74.9 nmol/mol)
and 27%(287) >9.0% (74.9 nmol/mol). From these preli-
minary results it is clear that a large proportion of parti-
cipants are not meeting recommended glycaemic targets
[1] despite the high uptake of intensified insulin therapy.
Further analysis of the ADDN dataset is needed to
understand the influence of different practices and thera-
pies for T1D used in Australian youth, and the clinical
and demographic predictors of glycaemic outcomes. This
research and resource will have major implications for
clinical investigation in Australasia and will provide an
evidence base to inform health policy.
On behalf of the ADDN Study Group.
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